Drug Markets/Methscopolamine Bromide

Methscopolamine Bromide

6 NDCs across 3 manufacturers|6 Generic,0 Brand

Methscopolamine Bromide is used to treat peptic ulcer, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved before 1982, and the first generic was approved Jan 1, 1982. In 2024, Medicare Part D spent $665K on Methscopolamine Bromide across 4,857 claims for 1,569 beneficiaries.

Methscopolamine Bromide is available as 6 NDCs from 3 manufacturers (6 generic, 0 brand), with NADAC prices from $0.55 to $1.49 per EAthe most expensive product costs about 2.7× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

6

6G / 0B

Manufacturers

3

competing in market

Price Spread

$0.55 – $1.49

per EA

7d Activity

60 flat

avg -2.5% WoW · of 6 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Drug Portfolio

6 NDCs total, 6 shown

Frequently Asked Questions

What is Methscopolamine Bromide used to treat?

Methscopolamine Bromide is used to treat peptic ulcer, per the National Library of Medicine's MED-RT classification.

When did Methscopolamine Bromide become available as a generic?

FDA approved the first generic Methscopolamine Bromide (ANDA) on Jan 1, 1982.

How much does Medicare spend on Methscopolamine Bromide?

In 2024, Medicare Part D spent $665K on Methscopolamine Bromide across 4,857 claims for 1,569 beneficiaries.

How many Methscopolamine Bromide products are on the market?

The Methscopolamine Bromide drug market contains 6 NDCs from 3 manufacturers — 6 generic and 0 brand products.

What is the price range for Methscopolamine Bromide?

NADAC reference prices for Methscopolamine Bromide range from $0.5506 to $1.4906 per EA — the most expensive product costs about 2.7× the cheapest.

Which manufacturers make Methscopolamine Bromide?

3 manufacturers list Methscopolamine Bromide in NADAC. Ranked by number of NDCs, the largest are Breckenridge Pharmaceutical Inc. (2), i3 Pharmaceuticals, LLC (2), Unichem Pharmaceuticals (USA) Inc. (2).

How has the price of Methscopolamine Bromide changed recently?

Over the past 7 days, 0 Methscopolamine Bromide NDCs rose and 6 fell, with a market-wide average change of -2.5%.